Diadema Partners »

Applied Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Applied Therapeutics (APLT) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Applied Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Applied Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applied Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $12k 19k 0.60

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Applied Therapeutics

T. Rowe Price Investment Management
Vestal Point Capital
Propel Bio Management
Knoll Capital Management
Vanguard Group
Simplify Asset Management
BlackRock
Pnc Financial Services
Pathstone Holdings
Marshall Wace
Adage Capital Partners GP
Rock Springs Capital Management
Franklin Resources
Millennium Management
UBS Group

View all funds holding Applied Therapeutics